Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease

Wiebe Jens; Doerr Oliver; Ilstad Hanna; Husser Oliver; Liebetrau Christoph; Boeder Niklas; Bauer Timm; Moellmann Helge; Kastrati Adnan; Hamm Christian W.; Nef Holger M.

首页> 外文期刊>JACC. Cardiovascular interventions >Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease

【24h】

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease

机译：everolimus-与非血栓血清洗脱的生物吸收支架，用于治疗冠状动脉疾病

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVES The purpose of this study was to compare the 1-year outcome of everolimus-eluting bioresorbable scaffolds (eBRS) and Novolimus-eluting bioresorbable scaffolds (nBRS) in patients undergoing percutaneous coronary intervention in a real-life clinical practice scenario.

机译：目的本研究的目的是比较维生素洗脱的生物化的支架（EBRS）和非血栓药物洗脱的生物或NBRS）的1年的结果，以在现实临床实践场景中进行经皮冠状动脉介入的患者中。

著录项

来源
《JACC. Cardiovascular interventions》 |2017年第5期|共9页
作者
Wiebe Jens; Doerr Oliver; Ilstad Hanna; Husser Oliver; Liebetrau Christoph; Boeder Niklas; Bauer Timm; Moellmann Helge; Kastrati Adnan; Hamm Christian W.; Nef Holger M.;
展开▼
作者单位

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

Deutsch Herzzentrum Munich Munich Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

Kerckhoff Heart &

Thorax Ctr Dept Cardiol Bad Nauheim Germany;

Deutsch Herzzentrum Munich Munich Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

Univ Giessen Dept Cardiol Med Klin 1 Klinikstr 33 D-35392 Giessen Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
bioresorbable scaffold; coronary artery disease; percutaneous coronary intervention;

机译：生物可吸收的脚手架;冠状动脉疾病;经皮冠状动脉介入;

相似文献

外文文献
中文文献
专利

1. Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease [J] . Wiebe Jens, Doerr Oliver, Ilstad Hanna, JACC. Cardiovascular interventions . 2017,第5期

机译：everolimus-与非血栓血清洗脱的生物吸收支架，用于治疗冠状动脉疾病
2. Poly (l-lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 11 randomized trials [J] . Verdoia Monica, Kedhi Elvin, Suryapranata Harry, Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions . 2020,第4期

机译：聚（L-乳酸）生物可吸收支架与金属药物洗脱支架用于治疗冠状动脉疾病：11种随机试验的META分析
3. Clinical outcomes following "off-label" versus "established" indications of bioresorbable scaffolds for the treatment of coronary artery disease in a real-world population [J] . Miyazaki Tadashi, Ruparelia Neil, Kawamoto Hiroyoshi, EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology . 2016,第13期

机译：在实际人群中，使用“可再吸收标签”相对“确定”适应症治疗可再吸收支架的临床结果
4. Design Control of Fully Bioresorbable Polyester Based Scaffold Development for Cardiovascular Disease Treatment [C] . Yunbing Wang World biomaterials congress . 2012

机译：完全生物可吸收聚酯基心血管疾病支架开发的设计控制
5. The Benefit of an Intensive Primary Prevention Program for Cardiovascular Disease in Low Versus Moderate Risk Groups Based Upon the Coronary Artery Calcium Score [D] . Rubin, Abbey. 2019

机译：基于冠状动脉钙评分的低与中度风险群体的心血管疾病密集初级预防计划的益处
6. Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients [O] . Beytullah Cakal, Sinem Cakal, Oguz Karaca, 2020

机译：everolimus-vss-of Novolimus-aluting的长期比较现实世界患者中的生物血清血管血管支架
7. SERIAL ANGIOGRAPHIC FOLLOW-UP AT 6 AND 18 MONTHS AFTER IMPLANTATION OF THE NOVEL NOVOLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD SYSTEM FOR THE TREATMENT OF SINGLE DE NOVO CORONARY LESIONS: A SUBANALYSIS OF THE DESOLVE NX CLINICAL TRIAL [O] . Costa Ricardo A., Abizaid Alexandre, de Ribamar Costa Jose, 2015

机译：新型线虫洗脱生物可吸收血管支架系统植入治疗单发性冠状动脉病变后的6个月和18个月的串行血管造影随访：解析NX临床试验的亚分析

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease

摘要

著录项

相似文献

相关主题

期刊订阅